Cancer BiologybioRxivPreprint
Targeted inhibition of SCF-SKP2 confers anti-tumor activities resulting in a survival benefit in osteosarcoma
J. Wang, A. Ferrena, S. Singh…·B. H. Hoang
This study shows that inhibiting SKP2 in osteosarcoma reduces tumor growth and improves survival, suggesting it as a potential therapeutic target.
DOI 10.1101/2023.05.13.540637